High-Risk Ewing Sarcoma: It Is Time to Break the Ceiling

被引：4
|
作者：
DuBois, Steven G. [1 ]
Gupta, Abha A. [2 ,3 ]
Palmerini, Emanuela [4 ,5 ]
机构：
[1] Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA
[2] Univ Toronto, Hosp Sick Children, Dept Paediat, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] IRCCS Ist Ortoped Rizzoli, Osteoncol Bone & Soft Tissue Sarcomas & Innovat T, Bologna, Italy
[5] Bologna Univ, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 21期
关键词：
D O I：
10.1200/JCO.22.00449
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2288 / +
页数：4
相关论文
共 50 条
  • [1] Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma
    De Angulo, Guillermo
    Hernandez, Mike
    Morales-Arias, Jaime
    Herzog, Cynthia E.
    Anderson, Peter
    Wolff, Johannes
    Kleinerman, Eugenie S.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (01) : 48 - 52
  • [2] High-dose treosulfan and melphalan for consolidation therapy in high-risk ewing sarcoma
    Abate, M. E.
    Paioli, A.
    Longhi, A.
    Cesari, M.
    Palmerini, E.
    Ferrari, S.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S328 - S329
  • [3] Megatherapy in children with high-risk Ewing's sarcoma in first complete remission
    Madero, L
    Muñoz, A
    de Toledo, JS
    Díaz, MA
    Maldonado, MS
    Ortega, JJ
    Ramírez, M
    Otheo, E
    Benito, A
    Salas, S
    BONE MARROW TRANSPLANTATION, 1998, 21 (08) : 795 - 799
  • [4] Megatherapy in children with high-risk Ewing’s sarcoma in first complete remission
    L Madero
    A Muñoz
    J Sánchez de Toledo
    MA Díaz
    MS Maldonado
    JJ Ortega
    M Ramírez
    E Otheo
    A Benito
    S Salas
    Bone Marrow Transplantation, 1998, 21 : 795 - 799
  • [5] Erratum: Prediction of high-risk Ewing's sarcoma by gene expression profiling
    Anat Ohali
    Smadar Avigad
    Rina Zaizov
    Ron Ophir
    Shirley Horn-Saban
    Ian J Cohen
    Isaac Meller
    Yehuda Kollender
    Josephine Issakov
    Isaac Yaniv
    Oncogene, 2005, 24 : 4319 - 4319
  • [6] Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone
    Ataergin, Selmin
    Ozet, Ahmet
    Solchaga, Luis
    Turan, Mustafa
    Beyzadeoglu, Murat
    Oysul, Kaan
    Arpaci, Fikret
    Komurcu, Seref
    Surenkok, Serdar
    Ozturk, Mustafa
    MEDICAL ONCOLOGY, 2009, 26 (03) : 276 - 286
  • [7] Long-lasting multiagent chemotherapy in adult high-risk Ewing’s sarcoma of bone
    Selmin Ataergin
    Ahmet Ozet
    Luis Solchaga
    Mustafa Turan
    Murat Beyzadeoglu
    Kaan Oysul
    Fikret Arpaci
    Seref Komurcu
    Serdar Surenkok
    Mustafa Ozturk
    Medical Oncology, 2009, 26
  • [8] INTENSIVE COMBINED MODALITY TREATMENT WITH AUTOLOGOUS MARROW INFUSION IN HIGH-RISK EWING SARCOMA PATIENTS
    KINSELLA, TJ
    GLAUBIGER, D
    TEPPER, JE
    DEISSEROTH, AB
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (09): : 1262 - 1263
  • [9] Treatment of patients with high-risk Ewing's sarcoma. A single-centre experience
    Dolgopolov, I.
    Ivanova, N.
    Shvarova, A.
    Boyarshinov, V.
    Petrosian, A.
    Igoshin, A.
    Pimenov, R.
    Yankelevich, M.
    Siegel, S.
    Mentkevich, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S17 - S17
  • [10] INTENSIVE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM CELLS IN EWING'S SARCOMA: PRELIMINARY RESULTS OF PROTOCOL ISG SSG IV FOR HIGH-RISK EWING'S SARCOMA
    Luksch, R.
    Tienghi, A.
    Abate, M.
    Fagioli, F.
    Prete, A.
    Tambunni, A.
    Bisogno, G.
    Favre, C.
    Mascarin, M.
    Del Prever, Brach
    Podda, M.
    Dileo, P.
    Barbieri, E.
    Gandola, L.
    Alvegaard, T.
    Ferrari, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : S27 - S27
12345